UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057284
Receipt number R000065483
Scientific Title Long-term Follow-up Study of Severely Obese Patients with Type 2 Diabetes Mellitus
Date of disclosure of the study information 2025/05/31
Last modified on 2025/03/14 11:10:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term Follow-up Study of Severely Obese Patients with Type 2 Diabetes Mellitus

Acronym

Long-term Follow-up Study of Severely Obese Patients with T2DM

Scientific Title

Long-term Follow-up Study of Severely Obese Patients with Type 2 Diabetes Mellitus

Scientific Title:Acronym

Long-term Follow-up Study of Severely Obese Patients with T2DM

Region

Japan


Condition

Condition

Severe Obesity patient with type 2 diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To observe the changes in body weight in patients with type 2 diabetes mellitus complicated by severe obesity and investigate the factors contributing to significant weight loss.

Basic objectives2

Others

Basic objectives -Others

To investigate the changes in renal function, liver function, lipid profile, and HbA1c associated with body weight changes.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Body weight

Key secondary outcomes

Renal function, lipid profile, liver function, and HbA1c


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with T2DM and severe obesity (BMI>=35)

Key exclusion criteria

Not applicable

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Noboru
Middle name
Last name Kurinami

Organization

Jinnouchi Hospital

Division name

Internal Medicine

Zip code

862-0976

Address

6-2-3 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto

TEL

0963630011

Email

kurinami@jinnouchi.or.jp


Public contact

Name of contact person

1st name NOBORU
Middle name
Last name KURINAMI

Organization

Jinnouchi Hospital

Division name

Internal Medicine

Zip code

862-0976

Address

6-2-3 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto

TEL

0963630011

Homepage URL


Email

kurinami@jinnouchi.or.jp


Sponsor or person

Institute

Jinnouchi Hospital

Institute

Department

Personal name



Funding Source

Organization

Non

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Jinnouchi

Address

6-2-3 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto

Tel

0963630011

Email

kurinami@jinnouchi.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

37

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 12 Month 31 Day

Date of IRB

2024 Year 12 Month 16 Day

Anticipated trial start date

2025 Year 01 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a retrospective long-term follow-up study on renal function in patients with type 2 diabetes mellitus and severe obesity, initially investigated in 2018. More than five years have passed, and this study aims to examine how baseline conditions and changes in treatment have influenced body weight fluctuations.


Management information

Registered date

2025 Year 03 Month 14 Day

Last modified on

2025 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065483